A Randomized, Double-blinded Placebo-controlled Study to Investigate Antimicrobial Efficacy and Safety Following Topical Application of DPK-060

Clinical trial NCT01522391 · COMPLETED

Trial details

NCT number: NCT01522391
Sponsor: DermaGen AB
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Atopic Dermatitis

Start date: 2008-03-01
Primary completion: 2009-04-01
Enrollment: 41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.